{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Morgantown",
      "state": "WV",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "90545",
      "recalling_firm": "Mylan Pharmaceuticals Inc",
      "address_1": "5005 Greenbag Rd",
      "address_2": "",
      "postal_code": "26501-7124",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Product was distributed nationwide within the United States",
      "recall_number": "D-1292-2022",
      "product_description": "Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDC 49502-394-71), packaged in cartons of 5 prefilled pens (NDC 49502-394-75), Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 15317, Manufactured for: Mylan Specialty L.P., Morgantown, WV",
      "product_quantity": "253,200 pens (50,650/5 per packs)",
      "reason_for_recall": "Labeling: Missing label: Label missing from some prefilled  pens.",
      "recall_initiation_date": "20220705",
      "center_classification_date": "20220726",
      "termination_date": "20240226",
      "report_date": "20220803",
      "code_info": "Lot #: BF21002895, Exp. Date Aug 2023",
      "more_code_info": ""
    }
  ]
}